Health Insurance covers Daxas from this month
Published: 2013-06-05 06:58:00
Updated: 2013-06-05 06:58:00
The Ministry of Health and Welfare said Monday that national health Insurance has covered Takeda Pharm’s Daxas (roflumilast), an oral treatment of chronic obstructive pulmonary disease (COPD; a group of diseases that affect the lungs and airways), from June 1.
According to the ministry, the in...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
